| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A study on the efficacy and safety assessment of Propionyl-L-carnitine tablets in treatment of intermittent claudication
|
Luo, Tao
|
|
2013
|
132 |
4 |
p. 427-432
6 p.
|
artikel
|
| 2 |
Cost-effectiveness of pharmacist-participated warfarin therapy management in Thailand
|
Saokaew, Surasak
|
|
2013
|
132 |
4 |
p. 437-443
7 p.
|
artikel
|
| 3 |
Distinct reactivity of the commercially available monoclonal antibodies of D-dimer and plasma FDP testing to the molecular variants of fibrin degradation products
|
Madoiwa, Seiji
|
|
2013
|
132 |
4 |
p. 457-464
8 p.
|
artikel
|
| 4 |
Editorial Board
|
|
|
2013
|
132 |
4 |
p. IFC-
1 p.
|
artikel
|
| 5 |
Efficacy and safety of the use of heparin as thromboprophylaxis in patients with liver cirrhosis: A systematic review and meta-analysis
|
Gómez Cuervo, Covadonga
|
|
2013
|
132 |
4 |
p. 414-419
6 p.
|
artikel
|
| 6 |
Intercellular transfer of tissue factor via the uptake of tumor-derived microvesicles
|
Lima, Luize G.
|
|
2013
|
132 |
4 |
p. 450-456
7 p.
|
artikel
|
| 7 |
Nonsense-mediated mRNA decay was demonstrated in two hypofibrinogenemias caused by heterozygous nonsense mutations of FGG, Shizuoka III and Kanazawa II
|
Soya, Keisuke
|
|
2013
|
132 |
4 |
p. 465-470
6 p.
|
artikel
|
| 8 |
Non-therapeutic anti-Xa levels in medical patients receiving anticoagulant therapy with enoxaparin
|
Ramos-Esquivel, Allan
|
|
2013
|
132 |
4 |
p. 433-436
4 p.
|
artikel
|
| 9 |
Novel homozygous fibrinogen Aα chain truncation causes severe afibrinogenemia with life threatening complications in a two-year-old boy
|
Štikarová, Jana
|
|
2013
|
132 |
4 |
p. 490-492
3 p.
|
artikel
|
| 10 |
Pharmacokinetic analysis of enoxaparin in a term neonate and review of literature
|
Mateos, Marion K.
|
|
2013
|
132 |
4 |
p. 487-489
3 p.
|
artikel
|
| 11 |
PON1 Q192R genotype influences clopidogrel responsiveness by relative platelet inhibition instead of on-treatment platelet reactivity
|
Li, Xiaoqi
|
|
2013
|
132 |
4 |
p. 444-449
6 p.
|
artikel
|
| 12 |
Receptors involved in cell activation by antiphospholipid antibodies
|
Brandt, Karim J.
|
|
2013
|
132 |
4 |
p. 408-413
6 p.
|
artikel
|
| 13 |
Recombinant thrombomodulin improved Stevens-Johnson syndrome with high serum high-mobility group-B1 DNA-binding protein induced by lenalidomide administered to treat multiple myeloma
|
Inoue, Yasuyuki
|
|
2013
|
132 |
4 |
p. 493-494
2 p.
|
artikel
|
| 14 |
The Clinical Implications of ADAMTS13 Function: The Perspectives of Haemostaseologists
|
Rangarajan, Savita
|
|
2013
|
132 |
4 |
p. 403-407
5 p.
|
artikel
|
| 15 |
The role of fibrin matrices and tissue factor in early-term trophoblast proliferation and spreading
|
Snir, Ayelet
|
|
2013
|
132 |
4 |
p. 477-483
7 p.
|
artikel
|
| 16 |
The role of soluble thrombomodulin in the risk stratification and prognosis evaluation of septic patients in the emergency department
|
Yin, Qin
|
|
2013
|
132 |
4 |
p. 471-476
6 p.
|
artikel
|
| 17 |
Thrombin Activatable Fibrinolysis inhibitor in Cancer Patients with and without Venous Thromboembolism
|
Radu, C.M.
|
|
2013
|
132 |
4 |
p. 484-486
3 p.
|
artikel
|
| 18 |
Timing of recurrent venous thromboembolism early after the index event: A meta-analysis of randomized controlled trials
|
Limone, Brendan L.
|
|
2013
|
132 |
4 |
p. 420-426
7 p.
|
artikel
|
Tijdschrift beschrijving